Civic Intelligence

T a G Treatment Action Group Inc.

990 • Fiscal year 2021 • EIN 13-3624785

Jan 01, 2021 to Dec 31, 2021 • Filed on Oct 05, 2022

Organization ProfileWWW.TREATMENTACTIONGROUP.ORG
90 Broad Street 2503New York, NY 10004

(212) 253-7922

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

55th percentile

0.09x

Higher debt load relative to assets than 55% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Liabilities / Revenue

57th percentile

0.13x

Higher debt load relative to revenue than 57% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Net Margin

7th percentile

-35%

Higher net margin than 7% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Top Officer Pay

87th percentile

$165,793

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 6.1% of source-year revenue.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2021

Asset Growth

5th percentile

-19%

Faster asset growth than 5% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2020 to 2021

Revenue Growth

6th percentile

-42%

Faster revenue growth than 6% of similar nonprofits.

2021 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2020 to 2021

Balance Sheet
Liabilities / Assets55th percentile

Assets

Down

$3,776,196

Down $873,217 (-19%) from 2020

Net Assets

Down

$3,420,105

Down $947,211 (-22%) from 2020

Liabilities

Up

$356,091

Up $73,994 (+26%) from 2020

Revenue And Expenses
Liabilities / Revenue57th percentileNet Margin7th percentile

Revenue

Down

$2,714,054

Down $1,976,600 (-42%) from 2020

Expenses

Up

$3,661,265

Up $673,432 (+23%) from 2020

Net Income

Down

-$947,211

Down $2,650,032 (-156%) from 2020

Historical Trend

Balance Sheet Trend

Asset Growth5th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $2,248,827Liabilities 2010: $2,860Net Assets 2010: $2,245,9672010Assets 2011: $2,679,042Liabilities 2011: $23,023Net Assets 2011: $2,656,0192011Assets 2012: $2,851,951Liabilities 2012: $25,636Net Assets 2012: $2,826,3152012Assets 2013: $1,880,235Liabilities 2013: $41,213Net Assets 2013: $1,839,0222013Assets 2014: $3,811,240Liabilities 2014: $30,523Net Assets 2014: $3,780,7172014Assets 2015: $3,609,971Liabilities 2015: $20,734Net Assets 2015: $3,589,2372015Assets 2016: $2,592,218Liabilities 2016: $74,083Net Assets 2016: $2,518,1352016Assets 2017: $2,575,844Liabilities 2017: $80,729Net Assets 2017: $2,495,1152017Assets 2018: $3,322,765Liabilities 2018: $67,916Net Assets 2018: $3,254,8492018Assets 2019: $2,736,460Liabilities 2019: $71,965Net Assets 2019: $2,664,4952019Assets 2020: $4,649,413Liabilities 2020: $282,097Net Assets 2020: $4,367,3162020Assets 2021: $3,776,196Liabilities 2021: $356,091Net Assets 2021: $3,420,1052021Assets 2022: $3,549,278Liabilities 2022: $931,291Net Assets 2022: $2,617,9872022Assets 2023: $4,624,032Liabilities 2023: $1,012,949Net Assets 2023: $3,611,0832023Assets 2024: $3,839,139Liabilities 2024: $745,777Net Assets 2024: $3,093,3622024

Highlighted filing

2021

Assets$3,776,196
Liabilities$356,091
Net Assets$3,420,105
Open 2021 Filing

Operations Trend

Revenue Growth6th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2010: $1,912,416Expenses 2010: $2,198,624Net Income 2010: -$286,2082010Revenue 2011: $1,886,646Expenses 2011: $1,677,094Net Income 2011: $209,5522011Revenue 2012: $2,042,960Expenses 2012: $1,872,664Net Income 2012: $170,2962012Revenue 2013: $1,458,571Expenses 2013: $2,437,127Net Income 2013: -$978,5562013Revenue 2014: $4,424,915Expenses 2014: $2,483,220Net Income 2014: $1,941,6952014Revenue 2015: $2,230,880Expenses 2015: $2,419,194Net Income 2015: -$188,3142015Revenue 2016: $1,623,672Expenses 2016: $2,690,029Net Income 2016: -$1,066,3572016Revenue 2017: $2,619,130Expenses 2017: $2,642,336Net Income 2017: -$23,2062017Revenue 2018: $1,809,214Expenses 2018: $2,510,963Net Income 2018: -$701,7492018Revenue 2019: $2,174,190Expenses 2019: $2,764,544Net Income 2019: -$590,3542019Revenue 2020: $4,690,654Expenses 2020: $2,987,833Net Income 2020: $1,702,8212020Revenue 2021: $2,714,054Expenses 2021: $3,661,265Net Income 2021: -$947,2112021Revenue 2022: $2,911,955Expenses 2022: $3,714,073Net Income 2022: -$802,1182022Revenue 2023: $4,736,176Expenses 2023: $3,743,080Net Income 2023: $993,0962023Revenue 2024: $3,574,921Expenses 2024: $4,092,642Net Income 2024: -$517,7212024

Highlighted filing

2021

Revenue$2,714,054
Expenses$3,661,265
Net Income-$947,211
Open 2021 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Oct 5, 2022
Return Version
2021v4.2
Gross Receipts
$2,731,354
Mission and Program Overview

Mission

Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.

Treatment action group (tag) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and lgbtq+ equity; social justice; and liberation, fighting to end hiv, tuberculosis (tb), and hepatitis c virus (hcv).tag catalyzes open collective action by affected communities, scientists, and policymakers to ensure that all people living with or impacted by hiv, tb, or hcv - especially communities of color and other marginalized communities experiencing inequities - receive life-saving prevention, diagnosis, treatment, care, and information.we are science-based activists working to expand and accelerate vital research and effective community engagement with research and policy institutions for an end to the hiv, tb, and hcv pandemics.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$1,498,766$1,836,278▲ $337,512
Pledges and Grants Receivable$2,465,371$1,346,450▼ $1,118,921
Prepaid Expenses and Deferred Charges$50,247$72,381▲ $22,134
Land, Buildings, and Equipment, Net$18,477$10,477▼ $8,000
Cash and Non-Interest-Bearing Accounts$72,598$4,269▼ $68,329
Accounts Receivable$1,252$0▼ $1,252
Total Assets$4,649,413$3,776,196▼ $873,217
Other Assets Total$542,702$506,341▼ $36,361
Liabilities
Unsecured Notes Loans Payable$214,717$301,325▲ $86,608
Accounts Payable and Accrued Expenses$48,767$43,011▼ $5,756
Other Liabilities$18,613$11,755▼ $6,858
Total Liabilities$282,097$356,091▲ $73,994
Net Assets / Fund Balance
Net Assets With Donor Restrictions$2,964,485$1,793,780▼ $1,170,705
Net Assets Without Donor Restrictions$1,402,831$1,626,325▲ $223,494
Total Net Assets Fund Balance$4,367,316$3,420,105▼ $947,211
Total Liabilities and Net Assets / Fund Balance$4,649,413$3,776,196▼ $873,217

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$9,963$58,784$68,747
Other Land Buildings$514$19,384$19,898
Other Assets Org$455,939--
Compensation and Service Providers
Top Officer Pay87th percentile

Employees

NameTitleFull / Part TimeBaseTotal
Mark HarringtonExecutive DirectorFT$165,793$165,793
Erica M LessemDeputy Executive DirectorFT$121,714$121,714

Board Members and Trustees

NameTitle
Robert W LennonPresident
Barbara HughesDirector
David I SigalDirector
Dick DadeyDirector
Eddie PeltoDirector
Jameel JiwaniDirector
Jim AquinoDirector
Joy EpisallaDirector
Kevin GoetzDirector
Nick DebsDirector
Richard Lynn PhdDirector
Robert MonteleoneDirector
Roy M Gulick Md MphDirector
Mrinal VikramSecretary
Laura MorrisonTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$2,695,387
Program Service Revenue
$16,090
Investment Income
$477
Other Revenue
$2,100
All Other Contributions
$2,237,084
Change in Net Assets
$-947,211

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,714,054
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$2,714,054
Total Revenue per Form 990
$2,714,054
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$2,112,524
Other Expenses$895,599
Grants and Similar Amounts Paid$653,142
Total Fundraising Expense$162,588
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$1,167,504$225,900$40,280$1,433,684
Grants to Domestic Orgs$528,736--$528,736
Other Employee Benefits$328,881$48,262$15,858$393,001
Fees for Services Other$335,608$6,376$10,960$352,944
Occupancy$139,622$24,600$8,557$172,779
Current Officers, Directors, Trustees, and Key Employees$121,029$11,606$33,158$165,793
Foreign Grants$124,406--$124,406
Payroll Taxes$100,460$14,742$4,844$120,046
Office Expenses$50,625$3,292$10,313$64,230
Information Technology$23,113$4,877$1,088$29,078
Conferences and Meetings$28,119--$28,119
Insurance$20,213$3,561$1,239$25,013
Fees for Services Accounting-$23,775-$23,775
Other Expenses$18,118$4,319$907$23,344
Travel$16,246$623$197$17,066
Fees for Services Lobbying-$11,368-$11,368
Depreciation Depletion$5,534$975$339$6,848
Fees for Services Legal-$3,750-$3,750
Advertising$1,274$35$1,809$3,118
Total Functional Expenses$3,110,003$388,674$162,588$3,661,265

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$3,661,265
Total Expenses per Audited Statements$3,661,265
Total Expenses per Form 990$3,661,265
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Prep4allBrooklyn, NY-Funds Paid Out as Fiscal Sponsor-hiv Advocacy$518,736
Act Up New York IncNew York, NY-Funds Paid Out as Fiscal Sponsor-hiv Advocacy$10,000

International Summary

Offices
0
Employees
0
Spending
$141,854

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Sub-saharan AfricaGrantsTb Advocacy--$72,547
South AsiaGrantsTb Advocacy--$29,609
Europe (including Iceland and Greenland)Program ServicesTb - Union Conference France--$16,000
Sub-saharan AfricaGrantsHcv - Lat Cab--$14,600
South AmericaGrantsTb Advocacy--$4,000
Europe (including Iceland and Greenland)GrantsHcv - Lat Cab--$3,650
Sub-saharan AfricaProgram ServicesHcv - Inhsu Conference--$1,204
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumProgram ServicesHcv - Virology Education Netherlands--$244
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$0
Fundraising Gross Income$0
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Riaa$198,167---
Total Events$198,167---
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent Liability$11,755
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of directors before the return was filed with the irs.”

Form 990, Part VI, Section B, Line 12C

“Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.”

Form 990, Part VI, Section B, Line 15

“Compensation for key employees is reviewed and approved by the executive director. Compensation for the executive director is reviewed and approved by the board of directors. This was last completed in march 2021.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents are available upon request. Annual reports are available on the organization's website.”

Filing and Contact Details

Filer

Filer Name
Tag Treatment Action Group Inc
EIN
13-3624785
Phone
2122537922
Address
90 BROAD STREET 2503, NEW YORK, NY 10004

Signing Officer

Name
Laura Morrison
Title
Secretary/treasurer
Phone
2122537922
Signed
2022-10-05
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Laura Morrison
Formed
1992
Legal Domicile
Ny
Voting Board Members
14
Independent Board Members
14
Employees
21
Volunteers
14

Preparer

Firm
Lutz and Carr Cpas Llp
Address
551 FIFTH AVE SUITE 400, NEW YORK, NY 10176
Preparer
Michael Wallace
Phone
2126972299
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 2

“Us & global health policy policy program staff work with program teams to develop specific policy goals and strategies to advance the end of the hiv, tuberculosis (tb), and hepatitis c (hcv) epidemics. This includes securing funding for, and shaping policy related to, government and multilateral programs that provide direct services, issue guidelines, coordinate administration, and conduct research on each of tag's priority health areas. Working with partners in the public and private sectors, the policy program advances a human-rights based approach to evidence-informed policy. This involves educating stakeholders and decision makers; authoring policy briefs containing information and recommendations; convening partners; leading and contributing to coalitions; submitting testimony, public comments, report language, and policy proposals; providing technical assistance and capacity building; and facilitating advocacy opportunities for communities most directly affected by the policies concerned. Given that hiv, tb, and hcv often impact many of the same communities, the policy program also seeks out potential areas for shared work and a population health approach. This sometimes means advocating for streamlined services and research, and expanding topic areas covered by individual programs. Throughout these efforts, the policy program maintains a commitment to our core principles and pushes policymakers to adopt bold visions for the end of these intersecting epidemics."”

Financial Statement Notes

PART III, LINE 4:

“The art prints are sold as part of the ticket package for major donors of the research in action awards event and subsequently sold as individual editions.”

Raw XML AppendixShowing 400 of 715 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt048767
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt043011
IRS990/AccountsReceivableGrp/BOYAmt01252
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS.
IRS990/AdvertisingGrp/FundraisingAmt01809
IRS990/AdvertisingGrp/ManagementAndGeneralAmt035
IRS990/AdvertisingGrp/ProgramServicesAmt01274
IRS990/AdvertisingGrp/TotalAmt03118
IRS990/AllOtherContributionsAmt02237084
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0CHRISTOPHER GEORGE
IRS990/BooksInCareOfDetail/PhoneNum02122537922
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt090 BROAD STREET SUITE 2503
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010004
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt072598
IRS990/CashNonInterestBearingGrp/EOYAmt04269
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt033158
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt011606
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0121029
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0165793
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt028119
IRS990/ConferencesMeetingsGrp/TotalAmt028119
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0198167
IRS990/CostOfGoodsSoldAmt017300
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02695387
IRS990/CYGrantsAndSimilarPaidAmt0653142
IRS990/CYInvestmentIncomeAmt0477
IRS990/CYOtherExpensesAmt0895599
IRS990/CYOtherRevenueAmt02100
IRS990/CYProgramServiceRevenueAmt016090
IRS990/CYRevenuesLessExpensesAmt0-947211
IRS990/CYSalariesCompEmpBnftPaidAmt02112524
IRS990/CYTotalExpensesAmt03661265
IRS990/CYTotalFundraisingExpenseAmt0162588
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02714054
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0339
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0975
IRS990/DepreciationDepletionGrp/ProgramServicesAmt05534
IRS990/DepreciationDepletionGrp/TotalAmt06848
IRS990/Desc0SEE SCHEDULE OTUBERCULOSIS (TB) PROGRAMACCORDING TO THE WORLD HEALTH ORGANIZATION, "THE COVID-19 PANDEMIC HAS REVERSED YEARS OF PROGRESS IN PROVIDING ESSENTIAL TB SERVICES AND REDUCING TB DISEASE BURDEN. GLOBAL TB TARGETS ARE MOSTLY OFF-TRACK, ALTHOUGH THERE ARE SOME COUNTRY AND REGIONAL SUCCESS STORIES. THE MOST OBVIOUS IMPACT IS A LARGE GLOBAL DROP IN THE NUMBER OF PEOPLE NEWLY DIAGNOSED WITH TB AND REPORTED. THIS FELL FROM 7.1 MILLION IN 2019 TO 5.8 MILLION IN 2020, AN 18% DECLINE BACK TO THE LEVEL OF 2012 AND FAR SHORT OF THE APPROXIMATELY 10 MILLION PEOPLE WHO DEVELOPED TB IN 2020... REDUCED ACCESS TO TB DIAGNOSIS AND TREATMENT HAS RESULTED IN AN INCREASE IN TB DEATHS. BEST ESTIMATES FOR 2020 ARE 1.3 MILLION TB DEATHS AMONG HIV-NEGATIVE PEOPLE (UP FROM 1.2 MILLION IN 2019) AND AN ADDITIONAL 214,000 AMONG HIV-POSITIVE PEOPLE (UP FROM 209 000 IN 2019), WITH THE COMBINED TOTAL BACK TO THE LEVEL OF 2017." (WHO GLOBAL TUBERCULOSIS REPORT 2021, PAGE 1.)THOUGH PREVENTABLE AND CURABLE, TUBERCULOSIS (TB) IS THE LEADING CAUSE OF DEATH OF PEOPLE WITH HIV, AND THE SECOND LEADING INFECTIOUS KILLER GLOBALLY BEHIND COVID-19. RECOGNIZING THAT MUCH MORE PROGRESS COULD BE MADE IF EXISTING TOOLS WERE FULLY IMPLEMENTED, AND THAT MORE RESEARCH IS NEEDED TO END TB, TAG'S TB PROGRAM STRENGTHENS EVIDENCE-DRIVEN AND HUMAN RIGHTS-BASED ADVOCACY BOTH FOR BETTER TB RESEARCH, AND FOR HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE, THAT MEET THE NEEDS OF AFFECTED COMMUNITIES.TAG'S TB PROGRAM EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE UNDERSTANDING OF TB AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROGRAM WORKS WITH COMMUNITY ADVOCATES, COMMUNITY ADVISORY BOARDS, RESEARCHERS, POLICY MAKERS, DEVELOPERS, AND DONORS TO ENSURE NEEDS-DRIVEN RESEARCH TO IMPROVE OPTIONS FOR TB PREVENTION, DIAGNOSIS, AND TREATMENT. THE TB PROGRAM PUBLISHES AN ANNUAL REPORT ON TB RESEARCH FUNDING TRENDS, AND ADVOCATES FOR ALL GOVERNMENTS OF THE WORLD TO STEP UP AND CONTRIBUTE THEIR "FAIR SHARE" INVESTMENTS IN TB R&D.THE TB PROGRAM WORKS AROUND THE WORLD TO ENSURE TRANSPARENCY AND BROAD, EQUITABLE, AFFORDABLE ACCESS TO PROVEN INTERVENTIONS, FROM EARLY IN THE RESEARCH PROCESS THROUGH REGULATORY APPROVAL TO GLOBAL AND NATIONAL GUIDELINES DEVELOPMENT AND PRODUCT PRICING. TAG'S POLICY TEAM SUPPORTS THE TB PROGRAM IN EDUCATING U.S. LEGISLATORS ON TB PRIORITIES, AND LEADS DOMESTIC WORK AT THE LOCAL, STATE, AND NATIONAL LEVEL TO SUPPORT AMBITIOUS AND EVIDENCE-BASED PROGRAMMING TO END.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt02964485
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt01793780
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt021
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01224100
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt023775
IRS990/FeesForServicesAccountingGrp/TotalAmt023775
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt03750
IRS990/FeesForServicesLegalGrp/TotalAmt03750
IRS990/FeesForServicesLobbyingGrp/ManagementAndGeneralAmt011368
IRS990/FeesForServicesLobbyingGrp/TotalAmt011368
IRS990/FeesForServicesOtherGrp/FundraisingAmt010960
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt06376
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0335608
IRS990/FeesForServicesOtherGrp/TotalAmt0352944
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0124406
IRS990/ForeignGrantsGrp/TotalAmt0124406
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt13.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.30
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.25
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt92.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.30
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt112.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt121.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt130.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1640.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/PersonNm0ROBERT W LENNON
IRS990/Form990PartVIISectionAGrp/PersonNm1LAURA MORRISON
IRS990/Form990PartVIISectionAGrp/PersonNm2MRINAL VIKRAM
IRS990/Form990PartVIISectionAGrp/PersonNm3JIM AQUINO
IRS990/Form990PartVIISectionAGrp/PersonNm4DICK DADEY
IRS990/Form990PartVIISectionAGrp/PersonNm5NICK DEBS
IRS990/Form990PartVIISectionAGrp/PersonNm6JOY EPISALLA
IRS990/Form990PartVIISectionAGrp/PersonNm7KEVIN GOETZ
IRS990/Form990PartVIISectionAGrp/PersonNm8ROY M GULICK MD MPH
IRS990/Form990PartVIISectionAGrp/PersonNm9BARBARA HUGHES
IRS990/Form990PartVIISectionAGrp/PersonNm10JAMEEL JIWANI
IRS990/Form990PartVIISectionAGrp/PersonNm11RICHARD LYNN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm12ROBERT MONTELEONE
IRS990/Form990PartVIISectionAGrp/PersonNm13EDDIE PELTO
IRS990/Form990PartVIISectionAGrp/PersonNm14DAVID I SIGAL
IRS990/Form990PartVIISectionAGrp/PersonNm15MARK HARRINGTON
IRS990/Form990PartVIISectionAGrp/PersonNm16ERICA M LESSEM
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt15165793
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt16121714
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt13DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt15EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt16DEPUTY EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01992
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0198167
IRS990/FundraisingDirectExpensesAmt00
IRS990/FundraisingGrossIncomeAmt00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt014
IRS990/GovernmentGrantsAmt0260136
IRS990/GrantAmt0106156
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0528736
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0528736
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt02731354
IRS990/GrossSalesOfInventoryAmt019400
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt014
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt01088
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt04877
IRS990/InformationTechnologyGrp/ProgramServicesAmt023113
IRS990/InformationTechnologyGrp/TotalAmt029078
IRS990/InsuranceGrp/FundraisingAmt01239
IRS990/InsuranceGrp/ManagementAndGeneralAmt03561
IRS990/InsuranceGrp/ProgramServicesAmt020213
IRS990/InsuranceGrp/TotalAmt025013
IRS990/InvestmentIncomeGrp/ExclusionAmt0477
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0477
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt036
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt078168
IRS990/LandBldgEquipBasisNetGrp/BOYAmt018477
IRS990/LandBldgEquipBasisNetGrp/EOYAmt010477
IRS990/LandBldgEquipCostOrOtherBssAmt088645
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS.
IRS990/MoreThan5000KToIndividualsInd01
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt04367316
IRS990/NetAssetsOrFundBalancesEOYAmt03420105
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/ExclusionAmt02100
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt02100
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt01402831
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt01626325
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt08557
IRS990/OccupancyGrp/ManagementAndGeneralAmt024600
IRS990/OccupancyGrp/ProgramServicesAmt0139622
IRS990/OccupancyGrp/TotalAmt0172779
IRS990/OfficeExpensesGrp/FundraisingAmt010313
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt03292
IRS990/OfficeExpensesGrp/ProgramServicesAmt050625
IRS990/OfficeExpensesGrp/TotalAmt064230
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0542702
IRS990/OtherAssetsTotalGrp/EOYAmt0506341
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt015858
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt048262
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0328881
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0393001
IRS990/OtherExpensesGrp/Desc0PRINTING & PUBLICATIONS
IRS990/OtherExpensesGrp/Desc1DUES AND SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc2FUNDRAISING EVENTS
IRS990/OtherExpensesGrp/Desc3MISCELLANEOUS
IRS990/OtherExpensesGrp/FundraisingAmt0930
IRS990/OtherExpensesGrp/FundraisingAmt156
IRS990/OtherExpensesGrp/FundraisingAmt232053
IRS990/OtherExpensesGrp/FundraisingAmt3907
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0613
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt14319
IRS990/OtherExpensesGrp/ProgramServicesAmt061235
IRS990/OtherExpensesGrp/ProgramServicesAmt139280
IRS990/OtherExpensesGrp/ProgramServicesAmt218118
IRS990/OtherExpensesGrp/TotalAmt062165
IRS990/OtherExpensesGrp/TotalAmt139949
IRS990/OtherExpensesGrp/TotalAmt232053
IRS990/OtherExpensesGrp/TotalAmt323344
IRS990/OtherLiabilitiesGrp/BOYAmt018613
IRS990/OtherLiabilitiesGrp/EOYAmt011755
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt040280
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0225900
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt01167504
IRS990/OtherSalariesAndWagesGrp/TotalAmt01433684
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt04844
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt014742
IRS990/PayrollTaxesGrp/ProgramServicesAmt0100460
IRS990/PayrollTaxesGrp/TotalAmt0120046
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt02465371
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt01346450
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt050247
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt072381
IRS990/PrincipalOfficerNm0LAURA MORRISON
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0OTHER PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt016090
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt016090
IRS990/ProgSrvcAccomActy2Grp/Desc0SEE SCHEDULE OHIV PROGRAMACCORDING TO UNAIDS, "IN 2020 THERE WERE 37.7 MILLION PEOPLE LIVING WITH HIV... 28.2 MILLION PEOPLE WERE ACCESSING ANTIRETROVIRAL THERAPY AS OF 30 JUNE 2021... 1.5 MILLION PEOPLE BECAME NEWLY INFECTED WITH HIV IN 2020... [AND] 680,000 DIED FROM AIDS-RELATED ILLNESSES IN 2020. 79.3 MILLION PEOPLE HAVE BECOME INFECTED WITH HIV SINCE THE START OF THE EPIDEMIC. (UNAIDS FACT SHEET -- WORLD AIDS DAY 2021.)TAG'S HIV PROGRAM WORKS TO MAXIMIZE EQUITABLE, AFFORDABLE ACCESS TO THE TOOLS, SERVICES, POLICIES, AND APPROACHES TO CARE THAT ARE ESSENTIAL FOR THE GOAL OF ENDING THE HIV EPIDEMIC DOMESTICALLY AND GLOBALLY. ADVOCACY FOCUSED ON ENDING THE EPIDEMIC (ETE) IS AT THE CORE OF THE HIV PROGRAM'S WORK, FROM DRIVING THE NATION'S FIRST ETE INITIATIVE IN NEW YORK TO LEADING THE ACT NOW: END AIDS (ANEA) COALITION'S SUPPORT FOR PARTNERS IN HEAVILY BURDENED JURISDICTIONS IN THE SOUTHERN U.S. TAG'S HIV AND POLICY TEAMS TACKLE ISSUES AROUND DRUG PRICING AND EQUITABLE ACCESS TO EMERGING BIOMEDICAL INTERVENTIONS; FUNDING FOR EVIDENCE-BASED HIV PROGRAMMING; ACCESS TO HEALTHCARE; AND POLICIES THAT PROMOTE SAFE, INCLUSIVE ENVIRONMENTS THAT ARE FREE OF STIGMA AND DISCRIMINATION FOR PEOPLE TO SEEK PREVENTION AND CARE FOR HIV AND RELATED INFECTIONS, INCLUDING SEXUALLY TRANSMITTED INFECTIONS. IN 2021, ANEA ADVANCED COMMENTS ON THE REVISED NATIONAL HIV/AIDS STRATEGY, ISSUED A COMMUNITY MEMO TO THE BIDEN/HARRIS TRANSITION TEAM, AND HOSTED EVENTS TO DISCUSS COMMUNITY CONCERNS WITH KEY FIGURES AT THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) AND THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS).TAG'S HIV PROGRAM LEADS RESEARCH ACTIVISM AND PROMOTES COMMUNITY ENGAGEMENT TO ENSURE THAT PEOPLE LIVING WITH HIV EVERYWHERE HAVE MORE OPTIONS INCLUDING, ULTIMATELY, A SAFE AND EFFECTIVE HIV VACCINE AND A CURE THAT'S SCALABLE, AFFORDABLE, AND CAN BE USED WORLDWIDE. TAG'S HIV PROGRAM RECOGNIZES THAT EVEN THE MOST EFFECTIVE EXISTING PREVENTION AND TREATMENT INTERVENTIONS HAVE SHORTCOMINGS. TO THIS END, TAG TRACKS THE ANTIRETROVIRAL, CURE, IMMUNE-BASED THERAPY, AND PREVENTION PIPELINES, AND PLAYS A VITAL LEADERSHIP ROLE IN BASIC SCIENCE, VACCINES, AND CURE ADVOCACY. OUR HIV CURE-RELATED CLINICAL TRIALS WEBSITE LISTING, UPDATED MONTHLY TO PROVIDE INFORMATION ON STUDIES AND THEIR RESULTS, IS WIDELY CITED BY RESEARCHERS AND PARTNERS IN SCIENTIFIC PAPERS AND IN CONFERENCE PRESENTATIONS. THE HIV PROGRAM ALSO ADVOCATES FOR APPROPRIATE INTERVENTIONS FOR PEOPLE WHO, DESPITE HIV TREATMENT, STILL HAVE POOR IMMUNE SYSTEM RECOVERY. CENTRAL TO THIS WORK IS ENSURING LEGISLATORS AND POLICY MAKERS UNDERSTAND THE NEED FOR RESEARCH FUNDING, AND HOW IMPORTANT IT IS TO MAKE DECISIONS BASED ON SCIENTIFIC EVIDENCE.UNDER THE HIV PROGRAM IN 2021, TAG CONDUCTED COMMUNITY ENGAGEMENT ACTIVITIES ON THE TOPICS OF BOTH BIOMEDICAL HIV PREVENTION AND COVID-19 IN COLLABORATION WITH THE BLACK AIDS INSTITUTE, SOUTHERN AIDS COALITION, THE HIV VACCINE TRIALS NETWORK, AND THE COVID-19 PREVENTION NETWORK. THE WEBINARS AND MATERIALS GENERATED ARE AVAILABLE ON TAG'S WEBSITE.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt01243883
IRS990/ProgSrvcAccomActy2Grp/GrantAmt0528736
IRS990/ProgSrvcAccomActy3Grp/Desc0SEE SCHEDULE OHEPATITIS C VIRUS (HCV) PROGRAMACCORDING TO THE WORLD HEALTH ORGANIZATION, "GLOBALLY, AN ESTIMATED 58 MILLION PEOPLE HAVE CHRONIC HEPATITIS C VIRUS INFECTION, WITH ABOUT 1.5 MILLION NEW INFECTIONS OCCURRING PER YEAR. WHO ESTIMATED THAT IN 2019, APPROXIMATELY 290 000 PEOPLE DIED FROM HEPATITIS C, MOSTLY FROM CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (PRIMARY LIVER CANCER).. ABOUT 2.3 MILLION PEOPLE (6.2%) OF THE ESTIMATED 37.7 MILLION LIVING WITH HIV GLOBALLY HAVE SEROLOGICAL EVIDENCE OF PAST OR PRESENT HCV INFECTION... OF THE 58 MILLION PERSONS LIVING WITH HCV INFECTION GLOBALLY IN 2019, AN ESTIMATED 21% (15.2 MILLION) KNEW THEIR DIAGNOSIS, AND OF THOSE DIAGNOSED WITH CHRONIC HCV INFECTION, AROUND 62% (9.4 MILLION) PERSONS HAD BEEN TREATED WITH DAAS BY THE END OF 2019." (WORLD HEALTH ORGANIZATION. HEPATITIS C. KEY FACTS -- 2 JUNE 2022.)TAG'S HCV PROGRAM HAS BEEN AT THE FOREFRONT OF A GLOBAL HCV EDUCATION AND ADVOCACY MOVEMENT, WORKING IN COLLABORATION WITH AFFECTED COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO MAKE LIFE-SAVING INFORMATION, HIGH QUALITY AND AFFORDABLE TESTING AND CURES, AND SUPPORTIVE ENVIRONMENTS FOR UNDERSERVED POPULATIONS UNIVERSALLY AVAILABLE. THIS INCLUDES TRACKING THE PIPELINE FOR HCV INNOVATIONS, INCLUDING THE LATEST PANGENOTYPIC TREATMENTS, DIAGNOSTICS, AND LONG-ACTING INJECTABLES, AND INCREASING COMMUNITIES' DIAGNOSTICS AND TREATMENT LITERACY. GLOBALLY, TAG PROVIDES TECHNICAL ASSISTANCE TO BUILD LEADERSHIP CAPACITY FOR ADVANCING NATIONAL ELIMINATION CAMPAIGNS AND AMPLIFYING COMMUNITY VOICES-ESPECIALLY THOSE OF KEY POPULATIONS SUCH AS PEOPLE WHO USE DRUGS, SEX WORKERS, PRISONERS, MIGRANTS, AND MEN WHO HAVE SEX WITH MEN-IN PLANNING AND POLICY DEVELOPMENT.TAG'S HCV PROGRAM AIMS TO OVERCOME BARRIERS TO ACCESS-FROM LIMITED DONOR FUNDING FOR HCV, TO SOBRIETY AND ADHERENCE RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, TO PATENT AND PRICING BARRIERS, TO LIMITED VOLUNTARY LICENSING AND DELAYS IN DRUG REGISTRATION BY ORIGINATOR COMPANIES. THE HCV PROGRAM ADVOCATES FOR HARM REDUCTION AND DRUG DECRIMINALIZATION EFFORTS, INCLUDING SUPPORT FOR OVERDOSE PREVENTION AND SAFE CONSUMPTION SITES, AS INJECTION DRUG USE WITHOUT ACCESS TO SAFE MATERIALS IS A MAJOR FACTOR IN HCV TRANSMISSION.IN THE U.S., TAG'S POLICY TEAM WORKS AT THE LOCAL, STATE, AND NATIONAL LEVELS: ADVOCATING FOR VIRAL HEPATITIS FUNDING, CHAMPIONING COVERAGE FOR PEOPLE WHO USE DRUGS, INCARCERATED OR OTHERWISE MARGINALIZED PEOPLE, ENCOURAGING VOLUME-BASED PRICING DEALS FOR DAAS, STRENGTHENING NATIONAL SURVEILLANCE AND SUPPORTING COMMUNITY ENGAGEMENT. TAG'S ADVOCACY HELPED ADVANCE COVERAGE FOR UNIVERSAL ADULT HCV SCREENING AND DRIVE NEW YORK STATE'S COMMITMENT TO ELIMINATE HCV-THE FIRST IN THE NATION!-WITH TAG PARTICIPATING IN THE RESULTANT STATEWIDE HCV ELIMINATION TASK FORCE.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0368732
IRS990/ProgSrvcAccomActy3Grp/GrantAmt018250
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt0273288
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt04662239
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0392308
IRS990/PYInvestmentIncomeAmt0737
IRS990/PYOtherExpensesAmt0741839
IRS990/PYOtherRevenueAmt01700
IRS990/PYProgramServiceRevenueAmt025978
IRS990/PYRevenuesLessExpensesAmt01702821
IRS990/PYSalariesCompEmpBnftPaidAmt01853686
IRS990/PYTotalExpensesAmt02987833
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt04690654
IRS990/QuidProQuoContributionsInd01
IRS990/QuidProQuoContriDisclInd01
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-947211
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt016090
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01498766
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01836278
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02695387
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt04662239
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02144930
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01781719
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt04077414
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt015361689
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0477
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0737
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt01347
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt01668
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01549
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt05778
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt085426
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus3YearsAmt05507
IRS990ScheduleA/OtherIncome170Grp/TotalAmt05507
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.50830
IRS990ScheduleA/PublicSupportPY170Pct00.50780
IRS990ScheduleA/PublicSupportTotal170Amt07814147
IRS990ScheduleA/SubstantialContributorsTotAmt07547542
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02695387

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2021 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$3,776,196
Liabilities
$356,091
Net assets
$3,420,105
Revenue
$2,714,054
Expenses
$3,661,265
Net income
-$947,211
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.84$0.75$3.09$3.57$4.09$0.52
2023Detailed filing. Detailed filing data is available for this year.$4.62$1.01$3.61$4.74$3.74$0.99
2022Detailed filing. Detailed filing data is available for this year.$3.55$0.93$2.62$2.91$3.71$0.80
2021Detailed filing. Detailed filing data is available for this year.$3.78$0.36$3.42$2.71$3.66$0.95
2020Detailed filing. Detailed filing data is available for this year.$4.65$0.28$4.37$4.69$2.99$1.70
2019Detailed filing. Detailed filing data is available for this year.$2.74$0.07$2.66$2.17$2.76$0.59
2018Detailed filing. Detailed filing data is available for this year.$3.32$0.07$3.25$1.81$2.51$0.70
2017Detailed filing. Detailed filing data is available for this year.$2.58$0.08$2.50$2.62$2.64$0.02
2016Detailed filing. Detailed filing data is available for this year.$2.59$0.07$2.52$1.62$2.69$1.07
2015Detailed filing. Detailed filing data is available for this year.$3.61$0.02$3.59$2.23$2.42$0.19
2014Detailed filing. Detailed filing data is available for this year.$3.81$0.03$3.78$4.42$2.48$1.94
2013Detailed filing. Detailed filing data is available for this year.$1.88$0.04$1.84$1.46$2.44$0.98
2012Summary only. Only limited summary data is available for this year.$2.85$0.03$2.83$2.04$1.87$0.17
2011Summary only. Only limited summary data is available for this year.$2.68$0.02$2.66$1.89$1.68$0.21
2010Summary only. Only limited summary data is available for this year.$2.25$0.00$2.25$1.91$2.20$0.29